John Cush reports an FDA safety warning for avacopan after dozens of drug-induced liver injury cases and deaths, emphasizing post-market surveillance and risk communication.
FDA has issued a drug safety warning for avacopan (Tavneos), dentifying 76 cases of drug-induced liver injury, including 7 cases of rare vanishing bile duct syndrome (VBDS).
There were 8 deaths
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare